RESUMEN
Indapamide--a non-thiazide diuretic agent--was given to 28 patients with mild and moderate hypertension in a daily dose of 2.5 mg for 12 weeks. Statistically significant decrease in both systolic and diastolic blood pressure and complete normalization of the arterial blood pressure were achieved in 82% of the treated patients. Adverse reactions were mild and transient. However, low but statistically significant decrease in blood serum potassium and changes in the carbohydrate metabolism were seen. No significant effect of the-drug on lipid metabolism was found except the low but statistically significant increase in total cholesterol. Indapamide is an efficient and well tolerated hypotensive agent. However, biochemical indices should be checked up during the treatment due to the potential adverse reactions.
Asunto(s)
Presión Sanguínea/efectos de los fármacos , Hipertensión/tratamiento farmacológico , Indapamida/uso terapéutico , Lípidos/sangre , Potasio/sangre , Adulto , Presión Sanguínea/fisiología , Femenino , Humanos , Hipertensión/fisiopatología , Hipopotasemia/inducido químicamente , Hipopotasemia/prevención & control , Indapamida/química , Indapamida/toxicidad , Masculino , Persona de Mediana Edad , Monitoreo FisiológicoRESUMEN
Human plasma fibronectin (FN) is not susceptible to collagenase and gelatinase from human blood leukocytes. Leukocytic elastolytic protease (ELP) and cathepsin G (chymotrypsin-like protease, CLP) degrade FN to similar fragments. Among products of proteolysis by ELP and CLP fragments have been identified which bind to gelatin-fragment 40 kd, to fibrin-fragments 55 kd and 30 kd, and to heparin-fragment 30 kd.
Asunto(s)
Endopeptidasas/farmacología , Fibronectinas/metabolismo , Leucocitos/enzimología , Humanos , NeprilisinaRESUMEN
Porcine elastase II (EC 3.4.21.-), a pancreatic proteinase with elastolytic activity, hydrolyses the oxidized beta-chain of insulin with major cleavages occurring at Leu17-Val18, Phe24-Phe25, Phe25-Tyr26 and Tyr26-Thr27. Canine leucocytic elastase splits the same substrate with major sites at Val12-Glu13 and Val18-Cys19 O3H. This indicates similarity of elastase II to chymotrypsins (EC 3.4.21.1 or 3.4.21.2) and of dog leucocyte enzyme to human granulocyte elastase and porcine pancreatic elastase I (EC 3.4.21.11).
Asunto(s)
Insulina/metabolismo , Leucocitos/enzimología , Páncreas/enzimología , Elastasa Pancreática/metabolismo , Secuencia de Aminoácidos , Animales , Perros , Sustancias Macromoleculares , Especificidad por SustratoRESUMEN
1. A neutral proteinase (EC 3.4.-.-) with elastolytic activity was isolated from canine bloodstream leucocytes, and purified to apparent homogeneity by a two-step procedure consisting of DEAE-Sephadex chromatography and molecular sieving on Sephadex G-75. 2. The molecular weight of the enzyme was 23 500, and the absorbance (A1%1cm) at 282 nm was 6.1. Amino acid analysis showed high content of glycine, aspartic acid, and valine, and low proportion of methionine, lysine and histidine as well as the absence of tyrosine in the enzyme molecule. 3. The proteinase was active against several protein substrates as well as towards N-t-butyloxycarbonyl-L-alanine p-nitrophenyl ester, N-acetyl-L-alanyl-tyrosine ethyl ester. 4. The enzyme was inactivated by diisopropylfluorophosphate, N-acetyl-L-alanyl-L-alanyl-L-alanine chloromethyl ketone, and N-p-tosyl-L-phenylalanine chloromethyl ketone. Inhibition by some natural proteinase inhibitors was also noted.